Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1.

Ryan, B M

Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Apr 2006 - 597-604 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

0923-7534

10.1093/annonc/mdj121 doi


Breast Neoplasms--metabolism
Cohort Studies
Female
Humans
Inhibitor of Apoptosis Proteins
Microtubule-Associated Proteins--metabolism
Neoplasm Proteins--metabolism
Plasminogen Activator Inhibitor 1--metabolism
Receptor, ErbB-2--metabolism
Survivin
Treatment Outcome
Urokinase-Type Plasminogen Activator--metabolism
Vascular Endothelial Growth Factor A--metabolism